BSEInsider Trading / SAST28 Sept 2026 · 28 Sept 2026, 10:26 am

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali

Aspira Pathlab & Diagnostics Ltd · 540788

✦ AI SummaryPledge

Aspira Pathlab & Diagnostics Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Jay Arvind Bhanushali, a promoter of the company, regarding the acquisition of 1424 equity shares, representing 0.013% of the total share capital.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk6/10
Balance Sheet Risk4/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Aspira Pathlab & Diagnostics Ltd - 540788 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

1B9BB6D5_E50F_46EB_A4F8_F7DD83361D7F_102556.pdf

pdf

Download →
View document text
JAY ARVIND BHANUSHALI Address: C-34, Konark Indraprashth, Sarvodaya Nagar, Village Nahur, Mulund (W), Mumbai – 400080 Date: 26/09/2026 BSE LIMITED Department of Corporate Services P J Towers, Dalal Street Fort, Mumbai 400 001 CC: Aspira Pathlab & Diagnostics Limited Flat NO.2 , R.D. Shah Bldg, Shraddhanand Road Opp. Ghatkopar Railway Station, Ghatkopar (West), Mumbai City, Maharashtra, India, 400086 Ref: Aspira Pathlab & Diagnostics Ltd (Scrip code: 540788) Sub: Disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 Dear Sir, Please find enclosed herewith the disclosure pursuant to requirement of Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 as Annexure “2” for acquisition of 1424 (0.013 %) Equity shares. Please take it on your record. Thanking you, Yours faithfully, Jay Arvind Bhanushali ANNEXURE ‐ 2 Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Name of the Target Company (TC) Aspira Pathlab & Diagnostics Ltd JAY ARVIND BHANUSHALI Name(s) of the acquirer and Persons Acting in Concert (PAC) with the acquirer Whether the acquirer belongs to Promoter/Promoter group Name(s) of the Stock Exchange(s) where the shares of TC BSE Ltd are Listed % w.r.t. total Details of the acqusition/ disposal as follows share/voting capital % w.r.t. total diluted wherever share/voting capital Number applicable(*) of the TC (**) Before the acquisition under consideration, holding of : a) Shares carrying voting rights JAY ARVIND BHANUSHALI 7,47,838 7.27 7.27 b) Shares in the nature of encumbrance (pledge/ lien/ non‐disposal undertaking/ others) 0.00 0.00 0.00 c) Voting rights (VR) otherwise than by shares 0.00 0.00 0.00 d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) 0.00 0.00 0.00 e) Total (a+b+c+d) 7,47,838 7.27 7.27 Details of Acqusition/Sale a) Shares carrying voting rights acquired/sold JAY ARVIND BHANUSHALI 1,424 0.01 0.01 b) VRs acquired /sold otherwise than by shares 0 0 0 c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold 0 0 0 d) Shares encumbered / invoked/released by the acquirer 0 0 0 e) Total (a+b+c+/‐d) 1,424 0.01 0.01 After the acquisition/sale, holding of: a) Shares carrying voting rights JAY ARVIND BHANUSHALI 7,49,262 7.28 7.28 c) VRs otherwise than by shares 0 0 0 d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition 0 0 0 e) Total (a+b+c+d) 7,49,262 7.28 7.28 Mode of acquisition / sale (e.g. open market / off‐market /public issue / rights issue / preferential allotment / inter‐ Pursuant to open market transfer etc). Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is 17‐09‐2026 to 24‐09‐2026 applicable Equity share capital / total voting capital of the TC before Rs. 10,29,30,000/‐ divided into 1,02,93,000 equity shares of Rs. the said acquisition / sale 10/‐ each Equity share capital/ total voting capital of the TC after the Rs. 10,29,30,000/‐ divided into 1,02,93,000 equity shares of Rs. said acquisition / sale 10/‐ each Total diluted share/voting capital of the TC after the said Rs. 10,29,30,000/‐ divided into 1,02,93,000 equity shares of Rs. acquisition 10/‐ each (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of JAY ARVIND BHANUSHALI Place: Mumbai Date: 26/09/2026